Predictors, Prognosis, and Management of New Clinically Important Atrial Fibrillation After Noncardiac Surgery

(Abstracted from Anesth Analg, 125(1):162–169, 2017) The purpose of the POISE (PeriOperative ISchemic Evaluation) trial substudy has multiple objectives: it aims to deduce the associations between new clinically important atrial fibrillation (AF) and patient outcomes, as well as patient management strategies, while identifying a valid clinical prediction model for new clinically important AF in patients undergoing noncardiac surgery.